Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The Society for Biomolecular Screening Awards Promega Scientist for Innovation

Published: Tuesday, September 11, 2012
Last Updated: Tuesday, September 11, 2012
Bookmark and Share
High Throughput Screening Award celebrates 'twinkles in the night'.

For outstanding contribution and innovation in the drug discovery area, The Society for Biomolecular Screening (SBS) has awarded Promega Corporation scientist Keith Wood the PerkinElmer Life Sciences Award for Innovation in Automation and High Throughput Screening. The award recognizes Dr. Wood's research and development of bioluminescent reporter gene technology.  Working with a team of scientists at the University of California, Dr. Wood cloned a gene responsible for the light in fireflies and showed how it could be used for measuring events within living cells.  After joining Promega in 1990, Dr. Wood further developed this technology to enable methods for rapid and reliable quantitation of over 100,000 biological samples per day.  This allows researchers to readily evaluate large compound libraries in search of new drugs.  Presently, Dr. Wood manages the Biomolecular Imaging and Reporters Program at Promega to develop other luminescent and fluorescent technologies for drug discovery.  The SBS grants this prestigious award at its 7th Annual Conference in Baltimore, Md.  on September 13.

According to Dr. John Westerfeld, Chair of the SBS Awards Committee, "Dr. Wood's work has led to important discoveries in basic research and has helped propel drug discovery to new frontiers."

He joins two eminent innovators recognized for significant accomplishments in life science research:  Dr. Leroy Hood and Dr. Michael Hunkapiller, recipients of the SBS Achievement Award.  This select group will present their perspectives at the SBS annual conference.

Dr. Wood will lecture on "High Throughput Technologies from Twinkles in the Night."  His research highlights how the fascinating phenomenon of bioluminescence has also been found to be invaluable as a tool for studying living processes.  The association of light with specific genes allows these genes to serve as unique beacons within the immense complexity of a living cell. As Dr. Wood describes, "By using luminous reporter genes, we can wire these natural lights into cells in a fashion similar to wiring LED's into electronic devices. They allow us to see what's happening as genetic 'circuits' are turned on or off."  Although the original research was based primarily on firefly enzymes, recent developments also involve enzymes from other organisms to provide new characteristics such as different colors.

Dr. Leroy Hood, M.D., Ph.D., of the Institute for Systems Biology, will lecture on his research which has focused on molecular immunology and biotechnology. His former UW laboratory has played a major role in developing automated microchemical instrumentation for the sequence analysis of proteins and DNA and the synthesis of peptides and gene fragments.  More recently, he has applied his laboratory's expertise in large-scale DNA mapping and sequencing to the analysis of the human and mouse T-cell receptor loci. His laboratory is also interested in the study of autoimmune diseases and new approaches to cancer biology.  His lecture is titled "Deciphering Life:  Genomics, Proteomics and Systems Biology."

Michael Hunkapiller, Ph.D., of Applera Corporation and Applied Biosystems  will lecture on "Transforming Life Science and Enabling Technologies."  Dr.  Hunkapillar and his team at Applied Biosystems Inc. put the first automated sequencing machine on the market in the mid-1980s. In the late 1990s, Dr.  Hunkapillar's group at PE Biosystems developed the lightning-speed PE Prism  3700 machine, which was used for all of Celera's sequencing and much of the  public Human Genome Project.

The mission of The Society for Biomolecular Screening is to provide a forum for education and information exchange amongst professionals within Drug Discovery and related disciplines.  In the process, The Society for Biomolecular Screening is committed to the highest standard of professional ethics.  The Life Sciences Award for Innovation in Automation and High Throughput Screening is co-sponsored by PerkinElmer.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Promega to Break Ground for New Processing and Manufacturing Facility
Facility will allow for efficiency improvements for processing, packaging, staging and shipping products.
Monday, July 07, 2014
Examine the Connection Between Consciousness and Nature
Experts explore consciousness through the perspective of intelligence in nature at the 2014 International Bioethics Forum: 3.8 Billion Years of Wisdom: Exploring the Genius of Nature.
Thursday, March 27, 2014
Rediscover Richard III, Explore the $1000 Genome and More at the 2013 International Symposium on Human Identification
24th International Symposium on Human Identification provides an opportunity for DNA analysts, members of law enforcement and other DNA industry professionals to learn about emerging forensic DNA techniques from experts in the field.
Thursday, August 15, 2013
Promega and MyBio Sign Exclusive Distribution Agreement
New partnership gives researchers and scientists in the University, Government and Commercial Laboratory Sector improved access to Promega’s world class product range.
Wednesday, June 12, 2013
Promega and BASF Develop Alternative Method on Identifying Allergenic Substances
Animal studies for cosmetic starting materials completely prohibited in the EU since March.
Thursday, April 11, 2013
Promega on Target with 2014 Environmental Goals
Promega is on target described in the 2011 Corporate Responsibility Report.
Monday, August 13, 2012
Promega Corporation Building New Facility to Support Regulated Product Manufacturing
cGMP facility to accommodate business growth and customers who need FDA-regulated molecular biology products.
Tuesday, September 06, 2011
Promega Partners with ATCC to Offer New Cell Systems for Biologics Drug Discovery
Partnership for the cell banking and bioproduction of cells to create a new line of bioluminescence-based drug discovery assays for biologics.
Monday, June 27, 2011
Promega Expansion into Brazil Brings New Convenience and Support for Scientists
Now scientists in life science research, drug discovery and clinical diagnostics have direct access to technical service, fast delivery and the ability to request a quote online in Brazil.
Thursday, April 07, 2011
Promega SABiosciences Agreement Enables the Most Sensitive Tools for Pathway Analysis
The Companies combine their offerings to provide sensitive tools for interrogation specific cellular pathways via transcription factor reporters.
Tuesday, August 18, 2009
Promega Signs Agreement with the Guangzhou Institute of Biomedicine and Health
The agreement is designed to co-develop compound profiling solutions for small molecule and traditional Chinese medicine drug screening.
Wednesday, April 11, 2007
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!